期刊文献+

干扰素对ICR乳鼠感染肠道病毒71型的保护作用 被引量:10

Interferon Protects Suckling ICR Mice against Enterovirus 71 Infection
原文传递
导出
摘要 目的探讨干扰素(Interferon,IFN)对ICR乳鼠感染肠道病毒71型(Enterovirus 71,EV71)的保护作用。方法将FY23-EV71感染经重组人IFNα1b和IFNλ1预处理的Vero和KMB17细胞,微量滴定法检测病毒滴度;取ICR乳鼠分为PBS对照组、EV71对照组和IFN保护组,临床观察2周,取乳鼠组织,观察病理学变化,并检测病毒含量。结果两种IFN对KMB17细胞和Vero细胞感染EV71均有保护作用,且IFNα1b的保护作用优于IFNλ1;IFN保护组乳鼠较EV71对照组乳鼠在临床表现、体重、病理变化和组织病毒含量等方面均表现出对EV71感染的保护作用。结论 IFN能抑制EV71的增殖,并对病毒致病性和组织嗜性有一定的影响。 Objective To investigate the protective effect of interferon(IFN) against enterovirus 71(EV71) infection in suckling ICR mice.Methods Vero and KMB17 cells previously treated with recombinant human IFNα1b and IFNλ1 were infected with FY23-EV71 and determined for virus titer by microtitration.Suckling ICR mice were infected with EV71 and treated with IFN,using those infected with PBS as negative control,and those untreated with IFN after EV71 infection as positive control,and observed for clinical signs for 2 weeks.The brain tissues of mice were collected,observed for pathological change,and determined for virus load.Results Both IFNα1b and IFNλ1 showed protective effect against EV71 infection in KMB17 and Vero cells,while the protective effect of IFNα1b was superior to those of IFNλ1.IFNα1b showed protective effect against EV71 infection in suckling mice,as proved by clinical sign,bodyweight,as well as pathological change of virus load in brain tissue.Conclusion IFN inhibited the replication of EV71,and showed a certain effect on pathogenicity and tissue tropism of EV71.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第7期824-827,共4页 Chinese Journal of Biologicals
基金 国家重大科技专攻艾滋病和病毒性肝炎等重大传染病防治专项(2008ZX10004-014) 国家重点基础研究973计划(2011CB504903)
关键词 干扰素Ⅰ型 肠道病毒71型 组织嗜性 免疫保护 Interferon type Ⅰ; Enterovirus 71(EV71); Tissue tropism; Immune protection
  • 相关文献

参考文献12

  • 1常宏伟,王明丽.人肠道病毒71型的研究进展[J].中国生物制品学杂志,2009,22(6):613-617. 被引量:7
  • 2Ank N, West H, Bartholdy C, et al. Lambda interferon (IFN- lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo [J]. J Virol, 2006, 80 (9): 4501-4509.
  • 3Ida-Hosonuma M, Iwasaki T, Yoshikawa T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of po- liovirus [J]. J Virol, 2005, 79 (7): 4460-4469.
  • 4Sitari H. Dual-label time-resolved fluor immunoassay for the simultaneous detection of adenovirus and rotavirus in faces [J]. J Virol Methods, 1990, 28 (2): 179-187.
  • 5李久立,田建丹,何凌冰,李晓红,王妍.重组人干扰素α2b阴道泡腾片抗豚鼠单纯疱疹病毒性阴道炎的疗效[J].中国生物制品学杂志,2007,20(9):674-676. 被引量:3
  • 6张淑子,李凡,易世红.重组人干扰素α2a凝胶对单纯疱疹病毒感染的疗效[J].中国生物制品学杂志,2006,19(6):607-609. 被引量:4
  • 7Arya SC. Antiviral therapy for neurological manifestations of enterovirus 71 infection[J]. Clin Infect Dis, 2000, 30 (6): 988-992.
  • 8Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family [J]. J Interferon Cytokine Res, 2010, 30 (8): 555- 564.
  • 9黄荣卫,李凌媛,杨瑞怡.α1b干扰素治疗手足口病临床疗效分析[J].山东医药,2010,50(12):80-81. 被引量:7
  • 10Wessely R, Klingel K, Knowhon KU, et al. Cardioselective in- fection with coxsackievirus B3 requires intact type 1 interferon signaling: implications for mortality and early viral replication [J]. Circulation, 2001, 103 (5) : 756-761.

二级参考文献54

  • 1许长江,王兵.α-干扰素制剂研究新进展[J].中国基层医药,2005,12(4):494-495. 被引量:4
  • 2朱俊萍,孙立连,卫灿东,李琳琳,金奇.肠道病毒71型感染前后宿主细胞蛋白质组的二维液相色谱分离和比较[J].病毒学报,2005,21(4):248-252. 被引量:5
  • 3杨智宏,朱启镕,李秀珠,王晓红,王建设,胡家瑜,唐伟,崔爱利.2002年上海儿童手足口病病例中肠道病毒71型和柯萨奇病毒A组16型的调查[J].中华儿科杂志,2005,43(9):648-652. 被引量:636
  • 4Yang TT, Huang LM, Lu CY, et al. Clinical features and facters of unfavorable outcomes for non-polio enterovirus infection of the centeral nervous system in northern Taiwan, 1994-2003. J Microbiol Immunol Infect, 2005, 38(6): 417-424.
  • 5Arita M, Ami Y, Wakita T, et al. Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol, 2008, 82(4): 1787-1797.
  • 6Schmidt N J, Lennett EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the centeral nervous system. J Infect Dis, 1974, 129 (3): 304-349.
  • 7Huang YP, Lin TL, Kuo CY, et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res, 2008, 137 (2): 206-212.
  • 8Brown BA, Oberste MS, Alexander JP Jr, et al. Molecular epidemiology and evolution of enterovirus 71 strains isolate from 1970 to 1998. J Virol, 1999, 73 (12): 9969-9975.
  • 9Hamaguchi T, Fujisawa H, Sakai K, et al. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. Emerg Infet Dis, 2008, 14 (5): 828-830.
  • 10Shih SR, Ho MS, Lin KH, et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand,foot and mouth disease during an epidemic in Taiwan, 1998. Virol Res, 2000, 68 (2): 127-136.

共引文献16

同被引文献75

  • 1陈培丽,张廷熹,胡英慧,周慈发,王申东,何政贤,陈虹,侯安存,李黎,刁在全.重组人干扰素-α1b治疗小儿病毒性肺炎多中心临床随机对照研究[J].临床儿科杂志,2005,23(4):244-245. 被引量:22
  • 2于德宪,陈清,张丽兰,刘翼,喻志爱,李志蜂,张丽萍,胡贵方,段招军,楚心唯,张滨,俞守义,侯云德.重组人干扰素α-2b喷雾剂预防SARS等呼吸道病毒感染的人群试验研究[J].中华实验和临床病毒学杂志,2005,19(3):216-219. 被引量:13
  • 3徐樨巍,王惠玲,王国丽,樊剑峰,侯安存,李黎,何政贤,陈虹.重组人干扰素-α1b治疗婴幼儿轮状病毒肠炎疗效观察[J].临床儿科杂志,2005,23(8):582-583. 被引量:28
  • 4BIBLE J M, PANTELIDIS P, CHAN P K, et al. Genetic evolu- tion of enterovirus 71 : epidemiological and pathological impli- cations [ J ]. Rev Med Viro1,2007,17 (6) : 371- 379.
  • 5CHEN S C,CHANG H L,YAN T R,et al. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan [J]. Am J Trop Med Hyg,2007,77( 1 ):188-191.
  • 6OSTERHAUS A. Antibodies to SARS-like virus hint at re- peated infections [ J ]. Nature,2004,427 : 185.
  • 7《手足口病诊疗指南(2010年版)》[EB/OL].http://www.mob.gov.cn/mohyzs/s3586/201004/46884.shtml.
  • 8《肠道病毒71型(EV71)感染重症病例临床救治专家共识》(2011年版)[EB/OL].http://www.nhfpc.gov.cn/yzygj/s3593/201105/203be457f36145058108fd818d9119db.shtml.
  • 9Lei X, Xiao X, Xue Q, et al. Cleavage of the interferon regulatory factor 7 by entervirus 71 3 C suppresses cellular responses [J]. J Virol ,2013,87 (3) :1690 - 1698.
  • 10Lu J,Yi L,Zhao J,et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1 [ J]. J Virol, 2012,86 (7) : 3767 - 3776.

引证文献10

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部